Skip to main content
PLOS One logoLink to PLOS One
. 2022 Dec 30;17(12):e0270127. doi: 10.1371/journal.pone.0270127

Modeling the spread of the Zika virus by sexual and mosquito transmission

Saitel Agudelo 1, Mario Ventresca 2,*
Editor: Martial L Ndeffo Mbah3
PMCID: PMC9803243  PMID: 36584063

Abstract

Zika Virus (ZIKV) is a flavivirus that is transmitted predominantly by the Aedes species of mosquito, but also through sexual contact, blood transfusions, and congenitally from mother to child. Although approximately 80% of ZIKV infections are asymptomatic and typical symptoms are mild, multiple studies have demonstrated a causal link between ZIKV and severe diseases such as Microcephaly and Guillain Barré Syndrome. Two goals of this study are to improve ZIKV models by considering the spread dynamics of ZIKV as both a vector-borne and sexually transmitted disease, and also to approximate the degree of under-reporting. In order to accomplish these objectives, we propose a compartmental model that allows for the analysis of spread dynamics as both a vector-borne and sexually transmitted disease, and fit it to the ZIKV incidence reported to the National System of Public Health Surveillance in 27 municipalities of Colombia between January 1 2015 and December 31 2017. We demonstrate that our model can represent the infection patterns over this time period with high confidence. In addition, we argue that the degree of under-reporting is also well estimated. Using the model we assess potential viability of public health scenarios for mitigating disease spread and find that targeting the sexual pathway alone has negligible impact on overall spread, but if the proportion of risky sexual behavior increases then it may become important. Targeting mosquitoes remains the best approach of those considered. These results may be useful for public health organizations and governments to construct and implement suitable health policies and reduce the impact of the Zika outbreaks.

1 Introduction

The Zika Virus (ZIKV) is a flavivirus similar to dengue, chikungunya and yellow fever, that is primarily transmitted by Aedes mosquitoes [1]. It was first identified in Uganda in 1947 and isolated from human blood in 1952 [1, 2]. Large Zika outbreaks have been reported in Micronesia (2007), French Polynesia (2013–2014), Easter Island (2014), the Cook Islands (2014), New Caledonia (2014–2015), and Brazil (2015), spreading rapidly to other zones [2, 3]. Generally, the Zika Fever has mild symptoms including fever, rash, conjunctivitis, asthenia, myalgia, arthralgia and vomiting [4, 5], which can generally be treated at home and are present in a small proportion of infected individuals [6]. Approximately, 20% of those who have Zika reported symptoms [6, 7].

It was long assumed that ZIKV was a typical vector-borne disease, transmitted only by Aedes mosquitoes [8]. However, recent studies have reported and confirmed ZIKV transmission during pregnancy [9], through breastfeeding [10], blood transfusions [11], organ transplantation [12], sexual contact [13], and other rare nonsexual person-to-person mechanisms [14]. The virus has also been found in fluids such as urine [15, 16], saliva [16, 17], semen [16, 18], breast milk [19] and cervical mucus [20]. The reports on ZIKV horizontal transmission correspond to individuals who became infected through sexual contact with a person who acquired the virus in a country with autochthonous transmission of the virus [13], even if the symptoms are absent [21, 22]. Though most non-vector-borne ZIKV infections involve transmission from a man to his female partner [13], male-to-male [13, 23], and female-to-male [13, 24] transmission has also been reported.

While ZIKV can be transmitted by various pathways, the most influential with respect to overall disease spread are by mosquito and sexual contact. Concerning the latter, ZIKV has a causal relationship with Guillain Barré syndrome (GBS) [25], an uncommon disorder that damages the peripheral nervous system and can lead to paralysis [26]. Zika also increases the probability of occurrence of microcephaly, the condition of babies born with heads smaller than the average expected size and not fully developed brains [27]. The probability of acquiring some other birth defects also increases when the infection is acquired during pregnancy [25]. The distinctive set of neurological, brain, ocular, joint, muscle and cranial anomalies observed in newborns encompass the congenital Zika Syndrome (CZS) [28].

The research agenda of the World Health Organization (WHO) on prevention and control is focused on vaccine development, vector control, treatment and regulatory support [29]. Although great effort has been put in the development of a vaccine, it is not yet available [30]. However, given the complications associated with ZIKV and its rapid propagation, it is nonetheless imperative to reduce the risk of becoming infected. As a part of this endeavor, the WHO has published guidelines on sexual transmission prevention [31], vector control [32], antenatal care [33, 34], breastfeeding [35], blood transfusion safety [36], and aircraft disinfection [37]. Surveillance recommendations in regard to Zika, Guillain-Barré syndrome, microcephaly and other congenital anomalies were also published [38, 39]. Concerning laboratory testing, the WHO advocates for prioritization of symptomatic individuals, especially those with possible sexual contact acquired ZIKV infection [40]. Identical action should be taken towards pregnant women who might have been exposed to ZIKV and their newborns [40].

According to the WHO, as of February 2018, interrupted transmission with potential re-introduction of ZIKV has been observed in 15 areas in the Western Pacific Region and the Americas [41]. Ongoing transmission, on the other hand, has been reported in 71 countries and territories, including 12 areas in Africa, 42 in the Americas, 6 in South-East Asia, and 11 in the Western Pacific Region [41]. In Colombia, the Ministry of Health and Social Protection confirmed the autochthonous circulation of ZIKV in October of 2015 (epidemiological week (EW) 41, 2015), after finding the first nine cases in the department of Bolivar [42]. The end of the epidemic phase of the outbreak was declared in July of 2016 when a decrease in the number of ZIKV infections was observed [43]. Following the epidemiological alert emitted in December 2015, that warned about the Zika Virus and its correlation with neurological syndromes and congenital anomalies [44], the Colombian National Institute of Health (INS) requested all of the entities involved in the surveillance system to intensify the observation process of congenital defects and perinatal deaths due to congenital defects [45]. During the epidemic phase, 377.7 infections per 100,000 urban population individuals (UPI) were reported, and during the post-epidemic phase ZIKV incidence decreased to 18.2 infections per 100,000 UPI by the end of 2016 [46], and to 7.74 cases per 100,000 UPI by the end of 2017 [47]. The INS affirm that 18,117 women were pregnant during the epidemic phase of the outbreak [48]. Among the children born from those women, between January 2016 and the first week of May 2017, 316 cases of microcephaly and other congenital defects of the central nervous system associated to the Zika Virus have been confirmed [48]. In the endemic period, from the second week of May 2017 to the last week of June 2018, another 31 cases associated with the Zika Virus had been confirmed [48]. Colombia has also reported severe ZIKV infections leading to patient death [49, 50].

In the context of ZIKV circulation, various mathematical models and parameter estimations have been proposed [5158]. The horizontal transmission of ZIKV was explored in [59] using a compartmental model that included human-to-human interactions under the assumption that asymptomatic individuals were not infectious, which has been disproved by [21, 22]. A subsequent approach [60] added asymptomatic individuals as contributors to the spread dynamics, but the model does not consider different periods of human-to-human and human-to-mosquito infectiousness, as [59]. Both of the aforementioned studies also assumed that symptomatic women and men had equal transmission probabilities and periods of infectiousness. The examination of scenarios where women-to-men and men-to-women transmission probabilities are different is relevant since more than 90% horizontal infections were reported as being male to female [13]. Moreover, ZIKV persistence in the genital fluids of male and female subjects has also been observed to be different [61, 62]. The model of [63] assumes equal women-to-men and men-to-women transmissibility, but incorporates different recovery rates for males and females. In a more recent study [64], all the considerations mentioned above are addressed, except for the fact that the model assumes that only men are able to infect other humans. None of the models considered the use of barrier methods in the population, which reduces the number of risky sexual encounters.

In this paper, we construct a compartmental model to represent the spread dynamics of ZIKV including its two main transmission pathways: mosquito bites and sexual contact. The structure of our model allows the simultaneous estimation of cases disaggregated by the presence of symptoms, transmission route, and sex. Symptomatic and asymptomatic individuals are able to spread the virus infecting mosquitoes and other humans. Following the kinetics of ZIKV, humans are infectious to mosquitoes for a shorter period than they are for other humans. Likewise, the infectious period of women and men is different and according to the persistence if the ZIKV is in semen or vaginal fluids. In consideration of the observed pattern of ZIKV sexual infections [13], women and men can infect each other with different transmission probabilities. Given that only one case of homosexual transmission has been documented [23], the model currently considers only heterosexual transmission.

In summary, the purpose of this study is multifaceted. One aim is to determine how significant is the contribution of the sexual transmission pathway to the spread dynamics of the ZIKV. To do this, we fit our model to the number of infections reported in 27 municipalities of Colombia [6567] as reported over the three-year period between 2015 and 2017. Since the surveillance reports involve a degree of under-reporting, where the symptomatic cases who do not receive medical care and the asymptomatic infections are not likely detected by the surveillance services, we also aim to estimate the degree of under-reporting. We do this by including an expansion factor to estimate the symptomatic and overall incidence of the disease and the proportion of vector-borne and sexually acquired ZIKV infections. The third primary aim of this work is to examine the efficacy of vector control and sexual prevention health policies on mitigation of the disease spread, including the exploration of scenarios where the contribution of the sexual transmission pathway changes.

2 Materials and methods

2.1 Mathematical model

In order to assess the impact of the sexual transmission pathway we build upon the model presented in [68], by adding compartments and associated parameters to represent the virus persistence in the genital fluids and the interactions between women and men. The additional parameters increased model complexity and a two-stage procedure was utilized to avoid poor local optima when fitting. The model we propose, according to present knowledge of ZIKV [21, 22], allows sexual transmission between humans regardless of whether infectious individuals have symptoms or not. We do not consider mosquito recovery given that arbovirus infection of mosquitoes generally lasts for the vector lifespan [69].

Fig 1 illustrates the proposed compartmental model, which is based on a susceptible-exposed-infectious-recovered (SEIR) framework. Susceptible men (Sm) are exposed (Em) to the virus through the bite of an infectious mosquito (Iv) or sexual contact with infectious women (Iwa, Iws, or Iw). After the latent period (1/λh), the men become infectious, and might (Ims) or might not (Ima) become symptomatic. The ZIKV disseminate in the blood and genital fluids of the infected individual. The mean time for clearance from blood is 1/γ1. The virus is cleared from semen and female fluids at a rate of 1/γ2 and 1/γ3 days, respectively, after clearance from blood. Therefore, men are able to infect mosquitoes and women for 1/γ1 days before the virus is cleared from their blood. Then, they remain infectious (Im) with viral load in semen, and are able to transmit the virus to women during 1/γ2 days, before they recover. Susceptible women (Sw) are exposed (Ew) to the virus through the bite of infectious mosquitoes (Iv) or sexual contact with infectious men (Ima, Ims, or Im). After the latent period, the women become infectious, and might (Iws) or might not (Iwa) develop symptoms. Women are able to infect mosquitoes and men for 1/γ1 days before the virus is cleared from their blood. Then, they remain infectious (Iw) with viral load in vaginal secretions, and are able to transmit the virus to men during 1/γ3 days before they recover. A susceptible mosquito (Sv) is exposed (Ev) when it bites infectious humans who have a viral load in their blood (Ims, Ima, Iws, Iwa). After the latent period, it becomes infectious (Iv).

Fig 1. Mosquito and sexual transmission model for the Zika Virus.

Fig 1

Susceptible men (Sm) and susceptible women (Sw) are exposed (Em, Ew) to the virus. After the latent period, they become symptomatically infectious (Ims, Iws) or asymptomatically infectious (Ima, Iwa). After 1/γ1 days the viral load is cleared from their blood, but can remain in their genital fluids (Im, Iw), before recovering. Susceptible mosquitoes (Sv) become exposed (Ev) and, after the latent period, infectious (Iv). Interactions between men, women and mosquitoes are depicted by broken lines.

Eqs 1 to 16 describe ZIKV infectious dynamics as depicted in the mathematical model shown in Fig 1. Note that the cumulative number of symptomatic infections (C) is recorded when simulating the model and used to calculate the symptomatic incidence during model fitting.

dSwdt=-βvhSwIv-βmwρSw(Ima+Ims+Im) (1)
dEwdt=βvhSwIv+βmwρSw(Ima+Ims+Im)-λhEw (2)
dIwsdt=ϕλhEw-γ1Iws (3)
dIwadt=(1-ϕ)λhEw-γ1Iwa (4)
dIwdt=γ1(Iws+Iwa)-γ3Iw (5)
dRwdt=γ3Iw (6)
dSmdt=-βvhSmIv-βwmρSm(Iwa+Iws+Iw) (7)
dEmdt=βvhSmIv+βwmρSm(Iwa+Iws+Iw)-λhEm (8)
dImsdt=ϕλhEm-γ1Ims (9)
dImadt=(1-ϕ)λhEm-γ1Ima (10)
dImdt=γ1(Ims+Ima)-γ2Im (11)
dRmdt=γ2Im (12)
dSvdt=νNv-βhvSv(Ims+Ima+Iws+Iwa)-νSv (13)
dEvdt=βhvSv(Ims+Ima+Iws+Iwa)-λvEv-νEv (14)
dIvdt=λvEv-νIv (15)
dCdt=λhϕ(Em+Ew) (16)

A summary of the parameter bounds are shown in Table 1. The rates of transmission between mosquitoes and humans is defined according to the convention of [70], which was also followed by [68] and discussed broadly with alternative approaches in [71]. Specifically, the transmission rate from humans to mosquitoes βhv (Eq 17) is the product of the blood feeding rate (a), and the virus transmissibility to mosquitoes (c).

βhv=a·c (17)

Table 1. Model parameters and their estimated realistic range.

Symbol Definition Range Reference
β vh Mosquito to human transmission rate 0.01–0.4 [59, 74, 77]
β hv Human to mosquito transmission rate 0.09–0.5 [59]
β wm Women to men transmission rate 0.001–0.1 [59]
β mw Men to women transmission rate 0.01–0.1 [59]
ϕ Proportion of symptomatic infections 0.10–0.27 [7]
1/λh Intrinsic latent period (days) 3–14 [81]
1/λv Extrinsic latent period (days) 8–12 [83]
1/γ1 Mean time to viral clearance from blood (days) 10–20 [88, 89]
1/γ2 Mean time to viral clearance from semen (days) 10–30 [89]
1/γ3 Mean time to viral clearance from vaginal fluids (days) 1–20 [61]
1/ν Mosquito life span (days) 4–50 [83]

The transmission rate from mosquitoes to humans βvh (Eq 18) is the product of the blood feeding rate (a), the virus transmissibility to humans (b), and the ratio of mosquitoes to humans (m).

βvh=m·a·b (18)

The ranges for a, b and c correspond to the values used in [59]. For m, the estimates of the ratio of female pupae per person were used, which is highly correlated to, and can be used to estimate, the risk of transmission [72, 73]. This ratio has also been reported in various survey studies conducted in different regions in Colombia [7477].

The person-to-person transmission rates (βwm, βmw) are in the range suggested in [59] and is consistent with the reported transmission probability per coital act reported for HIV [7880]. The model incorporates the assumption made in [55], that human latent period is equivalent to the intrinsic incubation period. The latent period of Zika (1/λh), as considered in our model, is thus the number of days before an infected person becomes symptomatically or asymptomatically infectious. The intrinsic incubation period for the Zika Virus was estimated in [81, 82], using those confidence we assume a constant λh = 6.8.

Similarly, the latent period for mosquitoes (1/λv) is the number of days before an infected mosquito becomes infectious. This interval was estimated in [83] for dengue, another Aedes-transmitted virus and is commonly used for ZIKV. In the model of [84] the similar confidence ranges are used. We follow this tradition, but assume a constant λv = 10, and also assume a constant mosquito life span of ν = 14 days.

According to the proposed mathematical model, an exposed individual becomes infectious with Zika viral load in blood and genital fluids. The viral clearance from blood occurs in (1/γ1). Whereas, the virus remains in semen for (1/γ2) days, and in vaginal fluids for (1/γ3) days. Most of the sexually transmitted ZIKV infections reported occurred between an infectious man and his partner [21, 22, 8587]. Though female-to-male transmission has been reported [24], it is understudied. The Zika Virus persistence in blood (1/γ1) has been estimated to be between 10–20 days [88, 89], noting that the persistence of the ZIKV in semen has been examined in different studies [9093] as well. The largest period of time that ZIKV has been detected in semen is six months after symptom onset [62]. The ZIKV persistence in semen estimates of a prospective cohort study in Puerto Rico [89] are often cited at 90 days, but given recent findings showing the efficacy of genital secretions from Zika infected men being extremely rare beyond 30 days [94], and in order to eliminate the contribution from outliers we use the median estimate reported (34 days (95%CI, 28 to 41). That is equivalent to a maximum of 20 days after viral clearance from blood (1/γ2). ZIKV has been detected in female genital secretions up to 37 days after onset of symptoms [61], but this has been rare to detect. As the persistence of ZIKV in the female track is still understudied, 20 days was used as the maximum duration of viral shedding in the genital secretions of symptomatic and asymptomatic women.

Although the Zika virus can be transmitted to people of all ages, only sexually active people can be horizontally infected. According to the Colombia Demographic and Health Survey 2015 [9597] 56.1% of women aged 13–49 and 62.2% of men in the same age group are sexually active. Traditional contraception methods such as periodic abstinence, withdrawal, and lactational amenorrhea method (LAM), and modern contraception methods such as sterilization, oral hormonal pills, intra-uterine device (IUD), injectables, and implants are not effective protection against sexually transmitted infections, thus individuals using those methods are at risk of being sexually infected with the ZIKV. The aforementioned study determined that 5.8% of married or in-union women and 16.4% of single but sexually active women use condoms, for a total of 22.2% [9597]. A higher percentage of use was observed for males, where 8.7% of married or in-union men and 46.0% of single but sexually active men reported to use condoms, totaling 54.7% [9597].

Thus, in Eq 19 the proportion of risky sexual interactions in the population (ρ) was calculated as the sum of the proportion of sexually active women of reproductive age who do not use condoms (Wnc) and the proportion of sexually active men of reproductive age who do not use condoms (Mnc), multiplied by the contact rate (CR), which was assumed to be monogamous and 2.5 times per week, assuming slight variations from the estimates in [98].

ρ=(Wnc+Mnc)·CR (19)

Approximately 7% of sexual interactions per person per day are risky encounters, which might lead to the horizontal transmission of the ZIKV. This calculation was made using the population estimates from years 1985–2005 and projections for 2005–2020 disaggregated by sex, area and five-year age groups [99] and the statistics of the Colombia Ministry of Health and Social Protection and the Association for the welfare of the Colombian Family (Profamilia) [9597]. Table 2 shows the estimated proportion of risky sexual encounters per municipality, calculated as in the Eq 19.

Table 2. Estimated at risk population by municipality.

Code Municipality Department Population at risk Risky sexual encounters ρ(%) Elevation (m)
8001 Barranquilla Atlantico 210234 7.24 18
8758 Soledad Atlantico 128930 7.40 58
13001 Cartagena Bolivar 245239 7.30 2
18001 Florencia Caqueta 36864 7.27 243
23001 Monteria Cordoba 182250 7.33 50
41001 Neiva Huila 57461 7.40 442
41298 Garzon Huila 21342 6.96 829
47001 Santa Marta Magdalena 126642 7.18 2
50001 Villavicencio Meta 73525 7.48 467
50006 Acacias Meta 13243 7.26 499
54001 Cucuta Norte de Santander 143381 7.29 321
54405 Los Patios Norte de Santander 13452 7.37 412
54874 Villa del Rosario Norte de Santander 17247 7.41 441
68001 Bucaramanga Santander 60300 7.29 959
68081 Barrancabermeja Santander 42763 7.19 75
68276 Floridablanca Santander 23708 7.39 926
68307 Giron Santander 24142 7.37 706
68547 Piedecuesta Santander 16858 7.32 1005
70001 Sincelejo Sucre 107681 7.26 180
73001 Ibague Tolima 76510 6.95 1286
76001 Cali Valle del Cauca 243657 7.33 1019
76111 Guadalajara de Buga Valle del Cauca 12237 6.96 969
76147 Cartago Valle del Cauca 20170 6.77 918
76520 Palmira Valle del Cauca 36748 7.22 1001
81001 Arauca Arauca 27506 6.73 125
85001 Yopal Casanare 30187 7.76 351
88001 San Andres San Andres 28987 7 85

2.2 Data sources

The political and administrative division of Colombia includes departments, intendencias, comisarías, municipalities, and population centers. Considering the heterogeneity of the population and the availability of data, municipalities were selected as cases of study. In order to show the impact of sexual transmission in representative territories within the 1,122 municipalities in Colombia, the largest 27 municipalities by number of reported infections will be used. These 27 municipalities each had at least 500 reported infections and accounted for 69.65% of the total infections reported on a national level.

2.2.1 Population at risk

The susceptible, exposed, infectious, and recovered compartments, are defined as proportions with respect to the population at risk (Nh), which is defined as the group of individuals residing in areas with average temperatures above 18°C and whose living conditions make them especially susceptible to vector-borne diseases. High temperatures are strongly correlated with a large number of vectors, and the occurrence of outbreaks [100]. Poverty, on the other hand, is associated with the lack of adequate infrastructure for the storage, distribution, and management of water and wastewater, which favors vector survival [101]. The number of individuals living in places with temperatures above 18°C, as calculated in [102], was scaled according to the Index of Unsatisfied Basic Needs published by the Colombian National Department of Statistics (DANE) [103]. This indicator is the result of the implementation of a methodology recommended by the United Nations Economic Commission for Latin America and the Caribbean (ECLAC) to identify severe deficiencies and characterize poverty in a population. An immunologically naive population with no prior immunity to ZIKV was assumed since this study encompasses the infections originated since the introduction of the ZIKV in Colombia in 2015 [42]. The model does not consider the impact of cross immunity; however, we consider it as a possible source of uncertainty in the discussion section.

The population of mosquitoes at risk was calculated using the proportions of female mosquitoes to humans reported in [73]. The proportion of women and men was calculated according to the population estimates from years 1985–2005 and projections for 2005–2020 disaggregated by sex, area, and five-year age groups, published by DANE [99].

Table 2 shows the code assigned to each municipality within the codification of the Political-Administrative Division (DIVIPOLA), the name of the municipality, the name of the department and the estimated corresponding human at-risk population.

2.2.2 Weekly incidence

The used weekly incidence data was reported to the Colombian National Public Health Surveillance System (SIVIGILA) from 2015 to 2017 as General Zika Disease (code 895), which includes neurological disorders probably associated with a ZIKV infection, and is available to the public in [6567]. Other ZIKV infections were reported as a part of broader epidemiological events: pregnant women were reported as Extreme Maternal Morbidity (code 549), newborns were reported as Congenital Defects (code 215) and the stillbirths and newborn deaths were reported as Perinatal or Late Neonatal Mortality (code 560) [104]. Although this data is also available to the public [6567], it was not considered here because it is not presented with a specific cause, making it impossible to identify specific ZIKV cases.

2.3 Fitting procedure

A multi-step fitting strategy is used whereby the first step performs a global search to obtain a suitable set of parameters that then is used as the initial estimate for the second (local search) step of the fitting process. In the former step, the cumulative symptomatic incidence (C) is fit to the cumulative number of reported infections per week. The result is a set of parameters that do not describe the incidence of the ZIKV. For that reason, in the latter step the symptomatic incidence per week is fit to the number of reported infections per week. A quasi-Newton method [105] was used to find the best set of parameters in this second step. This optimization method runs port routines [106] that discover a vector x that minimizes a function f(x), where x might be unconstrained or box-constrained. A bounds-constrained vector of parameters (see Table 1) is used to minimize a cost function, with constant values of λh, λv, ν and γ1 as indicated in the previous section. The cost function is calculated as the sum of squared weighted residuals as depicted in Eq 20, where w is the weight and a residual is the difference between the model prediction (Mod) and the number of cases reported (Obs).

cost=i=1n(Modi-Obsi)2·wi2 (20)

Because our model accounts for under-reporting, the weights are distributed so that the fitted points at the peak of the incidence curve have a greater penalty.

A Markov Chain Monte Carlo simulation that includes an adaptive Metropolis algorithm with a delayed rejection procedure is also leveraged to fit the data, which provides a confidence bound about its most probably parameterization. The method is executed for a maximum of 15000 iterations with a burn-in period of 3000 iterations.

The symptomatic incidence was fit to the reported infections, noting that the public health surveillance for the ZIKV in Colombia prior to and during the epidemic was based on the symptomatology exhibited by the patient [107, 108]. The confirmation of cases through laboratory tests was indicated for individuals coming from another country, individuals in areas without confirmed circulation of the virus and individuals in a risk group regardless of the area. The groups at risk include newborns (younger than two years of age), pregnant women, adults older than 65 years of age and individuals with co-morbidities. Clinical confirmation was indicated for individuals with Zika-like symptoms not attributable to other conditions who live in or come from areas with ongoing transmission of the virus.

The compartments of the model describe the prevalence of the ZIKV; not the incidence. In particular, the infectious compartments (Iwa, Iws, Iw, Ima, Ims, Im) describe the number of individuals that became infected at a given time (present or past) and remain infected at the current time. Taking that into account, the cumulative number of symptomatic infections per week (C) is recorded, and from that, it is possible to calculate the symptomatic incidence [55, 68].

2.3.1 Under-reporting

In addition to estimating model parameters, the degree of under-reporting is also estimated. As discussed above, under-reporting seems likely to occur given that approximately 80% of ZIKV cases seem asymptomatic [7], and might pass unnoticed. Additionally, considering that when the symptoms are present they are usually mild [109], it is logical to presume that most infected individuals do not seek medical care. There are various caveats to using the approach outlined below, which will be highlighted in the Discussion Section. Nevertheless, expansion factors have provided useful insight when studying related diseases such as Dengue [110].

The general idea is to artificially boost observed data to levels one would observe with full reporting. In order to estimate the total number of symptomatic cases, the data from SIVIGILA [6567] was modified by calculating an expansion factor (EF). First though, a multiplicative correction factor (CF) is applied to the reported cases prior to executing the fitting procedure. To determine this factor the fitting procedure was re-executed for multiple CFs, while estimating the best set of model parameters for each. The model parameters associated with the CF having minimum root mean square error (RMSE) was selected as the best fit. However, the CF alone does not properly reflect the under-reporting degree since it multiplies the number of symptomatic infections reported each week by the same quantity, with the best-fit parameters accounting for the remaining variation. An expansion factor for each municipality is therefore calculated as the ratio of estimated infections to reported symptomatic infections (EFs):

EFs=IestimatedIreported (21)

Then, an expansion factor (EF) for each of the 27 municipalities was calculated using the estimates for the proportion of symptomatic infections (ϕ) and the value of EFs:

EF=EFsϕ (22)

Hence, if the model is perfectly fit to reported data then CF = EFs and CFϕEF.

3 Results

For presentation purposes only figures for the municipalities af Barranquilla (8001), Giron (68307), Monteria (23001), Santa Marta (47001), Sincelejo (70001), Ibague (73001), Cali (76001), and Arauca (81001) are shown. These were empirically selected as a representative sub-sample by distribution of population sizes. The complete set of plots can be found in the S1 Appendix.

3.1 Estimated parameters for ZIKV infection

Using the best-fit parameters and correction factor from the Monte Carlo procedure, the number of weekly ZIKV infections from epidemiological week 1, 2015 through 52, 2017 was estimated. Infections were disaggregated by sex, symptomatology, and transmission pathway. The expansion factor was calculated for the symptomatic infections (EFs) and for the total number of infections (EF) are shown in Table 3, which also shows the estimated parameters and correction factor for the symptomatic infections in the 27 considered municipalities. The root-mean-square error (RMSE) of the compartmental model is also reported.

Table 3. Estimated errors, parameters, and correction factor for the symptomatic ZIKV infections.

Code Municipality CF RMSE β vh β hv β wm β mw ϕ γ 2 γ 3
8001 Barranquilla 7.4 0.00 0.1 0.4 0.03 0.05 0.16 0.09 0.13
8758 Soledad 20.60 0.00 0.23 0.16 0.01 0.04 0.16 0.08 0.39
13001 Cartagena 20.90 0.00 0.19 0.23 0.03 0.05 0.16 0.06 0.49
18001 Florencia 4.40 0.00 0.26 0.15 0.02 0.08 0.16 0.07 0.39
23001 Monteria 9.30 0.00 0.17 0.40 0.03 0.10 0.16 0.10 0.14
41001 Neiva 1.90 0.00 0.22 0.36 0.02 0.10 0.16 0.09 0.15
41298 Garzon 2.50 0.00 0.16 0.28 0.02 0.09 0.16 0.06 0.20
47001 Santa Marta 9.20 0.00 0.25 0.15 0.03 0.05 0.16 0.09 0.11
50001 Villavicencio 2.90 0.00 0.28 0.11 0.01 0.05 0.16 0.06 0.14
50006 Acacias 2.40 0.00 0.19 0.27 0.02 0.04 0.16 0.09 0.46
54001 Cucuta 2.10 0.00 0.18 0.30 0.00 0.02 0.16 0.09 0.23
54405 Los Patios 1.90 0.00 0.30 0.39 0.02 0.07 0.16 0.09 0.34
54874 Villa del Rosario 1.60 0.00 0.13 0.33 0.03 0.05 0.16 0.10 0.37
68001 Bucaramanga 1.20 0.00 0.23 0.13 0.01 0.06 0.16 0.06 0.11
68081 Barrancabermeja 4.40 0.00 0.28 0.09 0.01 0.07 0.16 0.09 0.48
68276 Floridablanca 1.20 0.00 0.26 0.14 0.02 0.04 0.16 0.06 0.18
68307 Giron 1.90 0.00 0.26 0.11 0.00 0.06 0.16 0.08 0.16
68547 Piedecuesta 2.30 0.00 0.15 0.20 0.03 0.01 0.16 0.06 0.13
70001 Sincelejo 13.70 0.00 0.10 0.40 0.03 0.10 0.16 0.10 0.12
73001 Ibague 4.60 0.00 0.12 0.32 0.01 0.09 0.16 0.06 0.11
76001 Cali 2.00 0.00 0.09 0.32 0.02 0.02 0.21 0.08 0.36
76111 Guadalajara de Buga 1.10 0.00 0.19 0.28 0.02 0.02 0.17 0.07 0.39
76147 Cartago 1.80 0.00 0.22 0.18 0.01 0.03 0.16 0.07 0.26
76520 Palmira 2.10 0.00 0.15 0.23 0.02 0.04 0.16 0.08 0.17
81001 Arauca 4.00 0.00 0.24 0.12 0.03 0.07 0.16 0.06 0.17
85001 Yopal 3.40 0.00 0.12 0.30 0.02 0.02 0.16 0.07 0.30
88001 San Andres 2.30 0.00 0.28 0.31 0.01 0.08 0.16 0.06 0.28

Among the municipalities, Soledad, Florencia, Neiva, Santa Marta, Villavicencio, Los Patios, Bucaramanga, Barrancabermeja, Floridablanca, Giron, Cartago, and San Andres exhibited relatively high vector-human transmission probabilities (βvh > 0.20). These estimates imply that the rapid increase in the number of ZIKV infections may be related to the short assumed latent periods. Interestingly, neither the female-to-male (βwm) or male-to-female (βmw) transmission probabilities exhibited any particularly obvious pattern or bias to specific values. These sexual transmission probabilities tend to be away from their minimum value though, implying that the pathways are not insignificant. No significant correlations were identified between sexual transmission and external variables such as population size.

Fig 2 shows a subset of municipalities over the two-year period considered, adjusted by CF, and compared to the proportion of symptomatic infections estimated using the mathematical model proposed herein. The aforementioned MCMC implementation was utilized to approximate sensitivity of the model to slight parameter changes, with a measure of confidence in the estimated model highlighted (see S1 Appendix for complete list of plots). A direct implementation of the compartmental model is included and depicted in each plot as a red line.

Fig 2. Comparing the adjusted proportion of observed symptomatic infections and the model output (See S1 Appendix for all plots).

Fig 2

Y-axis is a proportion (infected / at risk population), and the x-axis is time (in weeks).

3.2 Reporting degree

Table 4 compares the number of reported infections to the number of estimated infections, along with the correction and expansion factors for the symptomatic infections (EFs) and the total number of infections (EF). The estimates of EFs ranged from 0.95 to 25.63, with the highest underreporting degree in Cartagena and the smallest in Guadalajara de Buga. The estimates of EF ranged from 6.76 to 195.66, with Guadalajara de Buga as the municipality with the smallest overall underreporting degree and Cartagena the municipality with the highest. Guadalajara de Buga is the only municipality having EFs < 1, but all expansion factors are greater than one. The CF and Efs factors tend to have a small raw difference in value, implying that the fitted model may well-represent the observed data. Symptomatic expansion factors (EFs) for Bucaramagna, Floridablanca, and Guadalajara de Buga have their Efs±0.25, which shows a likely good surveillance process and/or high reporting rate. Using the model, we see that a under-reporting of symptomatic infections is a common occurrence, as is now well known. The lowest (EF = 159.20) and greatest (EF = 5.58) overall reporting degree were observed for Cartagena and Guadalajara de Buga, where 0.6% and 17.9% of overall ZIKV infections were estimated to have been reported, respectively. The high overall expansion factors were expected given that the proportion of symptomatic infections (ϕ) for most all of the municipalities was estimated to be at the lower permitted limit. It should be recognized that most of the highest expansion factor municipalities, e.g., Soledad, Cartagena, Monteria, Sincelejo, are high population areas but that population alone is insufficient to characterize the calculated EF. For instance, Cali is a high population municipality with low EF, but partly perhaps the difference could be partly attributed to it being approximately 1000m above sea level. Further discussion about this issue will be in Section 4.

Table 4. Comparison between the number of reported infections and estimated infections.

Code Municipality Reported infections Estimated infections Expansion factor
Symptomatic Total CF Ef s EF
8001 Barranquilla 2294 19534 121700 7.40 8.52 53.05
8758 Soledad 513 12157 75428 20.60 23.70 147.03
13001 Cartagena 921 23607 146627 20.90 25.63 159.20
18001 Florencia 542 3517 21855 4.40 6.49 40.32
23001 Monteria 1208 17980 112383 9.30 14.88 93.03
41001 Neiva 2268 5733 35735 1.90 2.53 15.76
41298 Garzon 723 2068 12825 2.50 2.86 17.74
47001 Santa Marta 1101 11997 74157 9.20 10.90 67.35
50001 Villavicencio 2061 6467 40247 2.90 3.14 19.53
50006 Acacias 511 1291 8053 2.40 2.53 15.76
54001 Cucuta 5462 14028 87462 2.10 2.57 16.01
54405 Los Patios 736 1346 8404 1.90 1.83 11.42
54874 Villa del Rosario 659 1650 10223 1.60 2.50 15.51
68001 Bucaramanga 4282 5350 33225 1.20 1.25 7.76
68081 Barrancabermeja 729 3496 21826 4.40 4.80 29.94
68276 Floridablanca 1872 2202 13738 1.20 1.18 7.34
68307 Giron 1019 2100 13080 1.90 2.06 12.84
68547 Piedecuesta 595 1485 9247 2.30 2.50 15.54
70001 Sincelejo 572 9902 61890 13.70 17.31 108.20
73001 Ibague 1386 7250 44578 4.60 5.23 32.16
76001 Cali 16053 31544 147798 2.00 1.96 9.21
76111 Guadalajara de Buga 1391 1328 7758 1.10 0.95 5.58
76147 Cartago 915 1949 11941 1.80 2.13 13.05
76520 Palmira 1524 3429 21131 2.10 2.25 13.87
81001 Arauca 557 2438 15178 4.00 4.38 27.25
85001 Yopal 690 2798 17326 3.40 4.06 25.11
88001 San Andres 1088 2999 18312 2.30 2.76 16.83

The proportion of symptomatic infections reported is smaller than 50% in municipalities except Los Patios (55%), Bucaramanga (80%), Floridablanca (85%), Cali (51%) and Guadalajara de Buga. Our estimates imply significant disparities in the rates of reporting across the municipalities and in general very low reporting rates reiterating the mildness of ZIKV symptoms.

The variation of the parameters and the expansion factor between different regions can be attributed to distinct geographic and socioeconomic conditions that favor transmission and might allow for superspreading events to occur. In these events, a small proportion of the population is responsible for a large proportion of cases. On the one hand, Colombia, being one of the countries that lie near the equator, has a very diverse climate that varies with the elevation and is more or less constant throughout the year. Thus, regions in lower elevations are much more suitable for mosquito breeding. On the other hand, the living conditions and the lack of access to water and sewage systems make some populations more likely to be exposed to mosquito clusters than others.

3.3 ZIKV infections disaggregated by symptomatology

Table 5 shows the total number of ZIKV infections estimated by municipality, along with the percentage of symptomatic and asymptomatic cases, disaggregated by sex. Given the generally low reporting rate (symbol ϕ) for each municipality model, it is expected that the numbers appear somewhat homogeneous across municipalities. The exception being Cali, where approximately 21% of individuals were symptomatic. In general, females were slightly more represented than males, which would follow literature such as [111], in that the concern about pregnancy might have introduced referral and testing bias, which led to a report where only 33.33% of the ZIKV infections correspond to males. This is also explainable by a number of reasons. First, the proportion of women is greater than the proportion of men in all the municipalities, aside from Garzon, Yopal, and Acacias. Second, the transmission rate from men to women (βmw) is equal or greater than the transmission rate from women to men (βwm).

Table 5. ZIKV infections disaggregated by symptomatology.

Code Municipality Estimated infections Symptomatic (%) Asymptomatic (%)
Women Men Total Women Men Total
8001 Barranquilla 121700 8.23 7.82 16.05 43.02 40.93 83.95
8758 Soledad 75428 8.14 7.98 16.12 42.36 41.52 83.88
13001 Cartagena 146627 8.29 7.81 16.10 43.20 40.70 83.90
18001 Florencia 21855 8.19 7.91 16.09 42.68 41.23 83.91
23001 Monteria 112383 8.23 7.77 16.00 43.19 40.81 84.00
41001 Neiva 35735 8.36 7.68 16.04 43.75 40.21 83.96
41298 Garzon 12825 7.74 8.38 16.12 40.27 43.60 83.88
47001 Santa Marta 74157 8.25 7.92 16.18 42.76 41.06 83.82
50001 Villavicencio 40247 8.23 7.83 16.07 43.01 40.92 83.93
50006 Acacias 8053 7.97 8.06 16.03 41.74 42.23 83.97
54001 Cucuta 87462 8.26 7.78 16.04 43.23 40.73 83.96
54405 Los Patios 8404 8.32 7.70 16.02 43.62 40.36 83.98
54874 Villa del Rosario 10223 8.15 7.99 16.14 42.34 41.52 83.86
68001 Bucaramanga 33225 8.31 7.79 16.10 43.30 40.60 83.90
68081 Barrancabermeja 21826 8.13 7.89 16.02 42.61 41.37 83.98
68276 Floridablanca 13738 8.34 7.69 16.03 43.71 40.26 83.97
68307 Giron 13080 8.08 7.97 16.06 42.26 41.68 83.94
68547 Piedecuesta 9247 8.19 7.87 16.06 42.78 41.16 83.94
70001 Sincelejo 61890 8.14 7.86 16.00 42.72 41.28 84.00
73001 Ibague 44578 8.36 7.91 16.26 43.03 40.71 83.74
76001 Cali 147798 10.99 10.36 21.34 40.49 38.17 78.66
76111 Guadalajara de Buga 7758 8.71 8.40 17.12 42.20 40.68 82.88
76147 Cartago 11941 8.42 7.90 16.32 43.20 40.48 83.68
76520 Palmira 21131 8.34 7.89 16.23 43.04 40.73 83.77
81001 Arauca 15178 8.11 7.95 16.06 42.38 41.56 83.94
85001 Yopal 17326 8.07 8.08 16.15 41.89 41.96 83.85
88001 San Andres 18312 8.24 8.14 16.38 42.05 41.57 83.62

3.4 ZIKV infections disaggregated by transmission pathway

Table 6 shows the total number of ZIKV infections estimated by municipality, along with the percentage of horizontal (sexually acquired) and vector-borne infections. The percentages of horizontal and vector-borne infections are also disaggregated by sex. According to these estimates, the proportion of sexually transmitted ZIKV infections can be as low as 0.5% and as high as 2.5%. These estimates are lower than the values presented in [59]: 4.44% (95% CI: 0.297%-23.02%), however, recent findings [94] imply that our lower estimate may be more realistic, especially given that a mosquito infection may be more likely to be first acquired. Although sexual transmission constitutes a small percentage of the total infections, the total number of cases is significant. The smallest proportion of horizontal infections was found in Cucuta, where 296 infections were sexually acquired. The largest proportion corresponds to Sincelejo, where 2974 infections were a result of the sexual transmission.

Table 6. ZIKV infections disaggregated by transmission pathway.

Code Municipality Estimated infections Symptomatic (%) Asymptomatic (%)
Women Men Total Women Men Total
8001 Barranquilla 121700 1.03 0.42 1.45 41.04 37.37 78.41
8758 Soledad 75428 0.96 0.14 1.10 39.65 38.89 78.54
13001 Cartagena 146627 1.08 0.24 1.33 41.25 37.14 78.40
18001 Florencia 21855 1.75 0.20 1.95 39.43 38.30 77.73
23001 Monteria 112383 1.39 0.35 1.74 40.86 37.40 78.26
41001 Neiva 35735 1.37 0.21 1.58 41.92 36.40 78.32
41298 Garzon 12825 1.62 0.24 1.86 34.89 43.14 78.04
47001 Santa Marta 74157 1.03 0.45 1.48 40.43 37.58 78.00
50001 Villavicencio 40247 1.38 0.26 1.64 40.65 37.49 78.14
50006 Acacias 8053 0.68 0.15 0.83 38.74 40.30 79.04
54001 Cucuta 87462 0.32 0.01 0.34 42.13 37.47 79.60
54405 Los Patios 8404 0.73 0.10 0.82 42.35 36.83 79.18
54874 Villa del Rosario 10223 0.94 0.27 1.21 39.62 38.72 78.33
68001 Bucaramanga 33225 1.63 0.23 1.86 40.96 36.86 77.82
68081 Barrancabermeja 21826 1.60 0.17 1.77 39.46 38.69 78.15
68276 Floridablanca 13738 1.20 0.23 1.43 42.31 36.24 78.54
68307 Giron 13080 1.36 0.05 1.41 38.95 39.46 78.41
68547 Piedecuesta 9247 0.42 0.50 0.92 41.33 37.60 78.93
70001 Sincelejo 61890 1.85 0.50 2.35 39.49 38.13 77.63
73001 Ibague 44578 2.14 0.11 2.25 39.61 37.30 76.91
76001 Cali 147798 0.36 0.22 0.58 36.98 32.07 69.05
76111 Guadalajara de Buga 7758 0.39 0.14 0.53 39.57 36.88 76.45
76147 Cartago 11941 0.59 0.04 0.64 41.73 36.73 78.46
76520 Palmira 21131 0.94 0.26 1.19 41.12 37.03 78.16
81001 Arauca 15178 1.83 0.40 2.23 38.70 38.86 77.56
85001 Yopal 17326 0.42 0.29 0.71 39.26 39.58 78.84
88001 San Andres 18312 1.04 0.07 1.11 38.84 38.94 77.77

3.5 Implementation of public health policies

One important use of disease spread models is to inform potential public policy decisions. To this end we simulated three hypothetical scenarios where a set of health policies are applied at specific points during the outbreak and assess the impact of the policy for mitigating ZIKV spread. These are not intended to be exhaustive, nor hyper-realistic. Rather, to further the discussion concerning uses of the proposed model.

The best-fit model for each municipality was used as a null model. Three time points were selected as the point where an intervention would occur by public policy, intended to coincide with levels of aggressiveness with respect to policy implementation: (a) Threshold(th) = 20%: when there were at least 20% of the maximum number of cases per week for the first time (Fig 3), (b) Threshold(th) = 50%: when there were at least 50% of the maximum number of cases per week for the first time (Fig 4), and (c) Threshold(th) = 80%: when there were at least 80% of the maximum number of cases per week for the first time (Fig 5).

Fig 3. Comparison of the proportion of symptomatic infections of the best fit and the behavior of the epidemics when policies are implemented at th = 20%.

Fig 3

Y-axis is a proportion (infected / at risk population), and the x-axis is time (in weeks). Best fit is dashed line, and policy 1,2, and 3 are colored blue, red, and purple, respectively.

Fig 4. Comparison of the proportion of symptomatic infections of the best fit and the behavior of the epidemics when policies are implemented at th = 50%.

Fig 4

Y-axis is a proportion (infected / at risk population), and the x-axis is time (in weeks). Best fit is dashed line, and policy 1,2, and 3 are colored blue, red, and purple, respectively.

Fig 5. Comparison of the proportion of symptomatic infections of the best fit and the behavior of the epidemics when policies are implemented at th = 80%.

Fig 5

Y-axis is a proportion (infected / at risk population), and the x-axis is time (in weeks). Best fit is dashed line, and policy 1,2, and 3 are colored blue, red, and purple, respectively.

  1. Policy one: Promoting the use of condoms during sexual encounters regardless of the marital status and the use of other non-barrier contraception methods. Scenario simulated: The proportion of risky sexual encounters (rho) decreases by 50%.

  2. Policy two: Promoting the use of insecticides and the destruction of larval breeding sites using public broadcasting. Scenario simulated: The population of mosquitoes is reduced by 10%.

  3. Policy three: Promoting the use of insecticides and the destruction of larval breeding sites more extensively, using public broadcasting and making visits to areas where poverty limits or restring the access to information media. Scenario simulated: The population of mosquitoes is reduced by 20%.

Table 7 shows the number of symptomatic and asymptomatic ZIKV infections that occurred during the outbreak null model (best-fit model output without policies) and the percentage reduction that each policy provides when applied at the three different above-stated points of the outbreak. The policies that implement vector control are more effective than the policy that promotes safe sexual practices, as expected. At th = 20%, policy two prevents typically 4–10 times as many infections across the 27 municipalities as policy one. Policy 3 prevents approximately 20–30 times as many cases as policy one, and 2.0–2.5 times as many cases as policy two. Similar proportions are observed for th = 50% and th = 80%.

Table 7. Percentage of reduction of ZIKV infections by policy.

Code Municipality Infections th = 20% th = 50% th = 80%
Policy 1 Policy 2 Policy 3 Policy 1 Policy 2 Policy 3 Policy 1 Policy 2 Policy 3
8001 Barranquilla 121721 0.27 2.46 5.88 0.26 2.36 5.59 0.24 2.25 5.26
8758 Soledad 74885 0.33 2.51 6.04 0.31 2.41 5.74 0.28 2.22 5.20
13001 Cartagena 146565 0.17 1.81 4.44 0.16 1.74 4.24 0.14 1.59 3.79
18001 Florencia 21616 0.24 2.41 5.85 0.23 2.32 5.58 0.20 2.13 5.03
23001 Monteria 112385 0.04 0.63 1.60 0.04 0.62 1.56 0.04 0.59 1.45
41001 Neiva 35659 0.02 0.39 1.00 0.02 0.38 0.98 0.02 0.36 0.91
41298 Garzon 12730 0.11 1.66 4.02 0.10 1.61 3.86 0.10 1.53 3.62
47001 Santa Marta 73505 0.29 2.71 6.57 0.27 2.56 6.11 0.25 2.41 5.67
50001 Villavicencio 39999 0.63 4.60 10.94 0.60 4.38 10.30 0.52 3.92 9.00
50006 Acacias 8011 0.10 1.40 3.47 0.09 1.34 3.29 0.09 1.26 3.04
54001 Cucuta 87314 0.15 1.09 2.69 0.15 1.07 2.62 0.14 1.02 2.48
54405 Los Patios 8399 0.00 0.07 0.21 0.00 0.07 0.21 0.00 0.07 0.20
54874 Villa del Rosario 10123 0.26 2.10 5.03 0.25 2.01 4.79 0.23 1.92 4.50
68001 Bucaramanga 32873 0.63 4.53 10.79 0.59 4.32 10.15 0.52 3.86 8.86
68081 Barrancabermeja 21276 1.12 7.18 16.89 1.04 6.71 15.46 0.90 5.86 13.08
68276 Floridablanca 13662 0.32 2.93 7.09 0.30 2.79 6.67 0.27 2.55 5.98
68307 Giron 13122 0.59 4.52 10.73 0.55 4.25 9.96 0.50 3.93 9.02
68547 Piedecuesta 9095 0.68 4.86 11.57 0.64 4.59 10.77 0.56 4.11 9.40
70001 Sincelejo 61892 0.28 2.65 6.31 0.27 2.57 6.08 0.25 2.40 5.59
73001 Ibague 44024 0.27 2.63 6.28 0.26 2.54 6.00 0.24 2.36 5.48
76001 Cali 154490 0.28 5.48 12.95 0.27 5.21 12.14 0.24 4.74 10.80
76111 Guadalajara de Buga 8000 0.07 1.01 2.54 0.06 0.97 2.40 0.06 0.90 2.19
76147 Cartago 11755 0.32 2.28 5.44 0.31 2.19 5.18 0.29 2.09 4.89
76520 Palmira 20685 0.44 3.63 8.70 0.41 3.45 8.19 0.37 3.18 7.41
81001 Arauca 15131 0.50 4.30 10.28 0.46 4.03 9.46 0.41 3.68 8.46
85001 Yopal 17089 0.40 3.05 7.24 0.39 2.95 6.94 0.36 2.76 6.40
88001 San Andres 18041 0.01 0.26 0.68 0.01 0.25 0.67 0.01 0.25 0.65

3.6 Variation of the number of risky sexual interactions

We also explored two feasible scenarios where the proportion of sexual interaction without the use of sexual protection (e.g., condoms) increases. On the one hand, we explore the case in which the number of sexual encounters per week increases resulting in a proportion of unsafe sexual interactions of 10%. Secondly, we additionally assume that individuals have two sexual partners per year, then rho increases to 20%. The second scenario will also occur if the number of sexual encounters per week increases. Fig 6 shows the comparison between the best fit results and the output of the model when the proportion of unprotected sexual interaction increases and shows significant increases if ρ ≥ 0.2, and for example Sincelejo (70001) and Arauca (81001) see nearly doubles proportions.

Fig 6. Comparison of the proportion of symptomatic infections of the best fit and the behavior of the epidemics when the number of risky sexual interactions increases.

Fig 6

Y-axis is a proportion (infected / at risk population), and the x-axis is time (in weeks). Best fit is dashed line, blue corresponds to ρ = 0.10, and red is ρ = 0.20.

Table 8 shows the number of symptomatic and asymptomatic ZIKV infections that occurred during the outbreak and the percentage of new ZIKV infections when the proportion of risky sexual interactions increases. If the proportion of risky sexual interactions increases to 10% there would be additional infections. In the case that rho increases to 20% there would be an increment of 80,479 infections, with respect to the value used to fit the model. The results of these simulations show that a slightly higher proportion of unprotected sexual interactions, given either by the increase of the number of sexual partners per year or by the frequency of sexual encounters, might lead to a significant number of additional ZIKV infections. Therefore, although horizontal transmission is not the main pathway of Zika, the implemented policies should also promote the use of condoms or other forms of sexual protection as a safe sexual practice that minimizes the acquisition of sexual infections and, in the case of ZIKV, reduces the propagation of the virus.

Table 8. Percentage of increment of ZIKV infections according to the proportion of unprotected sexual interactions.

Code Municipality Infections Increment (%)
ρ = 10% ρ = 20%
8001 Barranquilla 121841 2.96 4.82
8758 Soledad 75626 2.16 3.44
13001 Cartagena 146952 1.84 2.82
18001 Florencia 21905 2.55 3.44
23001 Monteria 112385 0.61 0.88
41001 Neiva 35773 0.31 0.42
41298 Garzon 12862 1.65 2.28
47001 Santa Marta 74448 3.05 4.81
50001 Villavicencio 40313 5.82 8.76
50006 Acacias 8062 0.70 1.19
54001 Cucuta 87541 0.33 0.60
54405 Los Patios 8410 0.03 0.05
54874 Villa del Rosario 10256 1.84 3.03
68001 Bucaramanga 33303 6.06 8.70
68081 Barrancabermeja 21837 8.80 12.86
68276 Floridablanca 13749 3.19 4.81
68307 Giron 13101 5.00 7.36
68547 Piedecuesta 9261 3.74 6.62
70001 Sincelejo 61892 4.11 5.95
73001 Ibague 44832 3.71 4.65
76001 Cali 155347 3.36 6.23
76111 Guadalajara de Buga 7917 0.50 0.90
76147 Cartago 12024 1.56 2.61
76520 Palmira 21237 3.14 5.12
81001 Arauca 15202 6.81 9.41
85001 Yopal 17387 1.83 3.39
88001 San Andres 18459 0.11 0.14

4 Discussion

We presented a deterministic model for the Zika Virus spread as both a vector-borne and sexually transmitted disease. Our model encompasses transmission of the virus between humans and mosquitoes, and between women and men regardless of the presence or absence of symptoms. Our analysis disaggregated the estimated infections according to the sex, symptomatology and transmission pathway. We also evaluated the reporting degree for the symptomatic infections and the total ZIKV infections. While the proposed model has been demonstrated to well-fit the observed patterns for most of the municipalities, there are some important aspects to discuss concerning the model, its assumptions, and potential influential external factors.

Firstly, the proposed transmission model does not consider male-male, or female-female transmission, which although comprise a small proportion of all cases, does contribute to the spread dynamics. The model also does not consider environmental factors such as sea level that have been observed to be high related to ZIKV incidence, mostly by influencing the mosquito population (more below). Moreover, the model does not consider cross-immunity directly as it assumes the population of susceptible men and women is relatively well known, similar for the susceptible mosquito population. Due to the number of parameters the fitting procedure needed to be multiple-stages to avoid being trapped at local optimal that may not have practical relevance. Increased data or improved knowledge of the parameterization will reduce this issue. Additionally, the model was fit for each of the 27 municipalities independently, however, there are model parameters that should have similar values independent of the location such as the mean time to viral clearance in semen or vaginal fluid. Perhaps a more sophisticated higher-order model could be constructed and fit that is able to better make use of the data and represent such constraints.

The population at risk is estimated based on the average temperature and Index of Unsatisfied Basic Needs, which impacts the number of susceptible individuals and hence is an important factor to the overall disease spread. In this paper we assumed previous literature values, but calibrating this value is of critical importance. Of course, there are a variety of risk factors behind the geographical spread and transmission of ZIKV, for instance the inverse relationship between ZIKV and gross domestic product [112]. The mosquito population is also at risk and it is known that temperature also plays an important role [113, 114], and will vary between the affected municipalities. Temperature will vary through the year, and including this behavior into our model could improve the predictions further, especially for the few cases with very high correction factors.

The number of infections was adjusted using the a correction factor (the CF value) and their distribution in time by searching for the set of best fit parameters. The CF is applied uniformly to all time points, which is unlikely to be true in general, for instance as public awareness increases to attain more accurate reporting. Nevertheless, our results indicate significant levels of under-reporting in most municipalities seems likely. For example, the ZIKV infections reported in Monteria, Cucuta, Villa del Rosario and Florencia have a rapid increase, plausibly due to high levels of under-reporting at the beginning and at the end of the epidemic, respectively. On the other hand, the distribution of infections in Garzon and Acacias indicate a high level of under-reporting at the beginning of the outbreak only. The number of infections reported in Cartagena and Santamarta fluctuates over time, and could be due to inconsistent reporting of ZIKV infections throughout the epidemic. The results also suggest that some of the cases reported near the peak of infections in Neiva, Los Patios, Barrancabermeja, Guadalajara de Buga and San Andres, correspond to previous weeks. External factors, such as sea level, are likely also represented in this correction factor.

The data could be limited in a number of ways as well. The National System of Public Health Surveillance in Colombia (SIVIGILA) publishes time series of the number of symptomatic Zika infections that are confirmed clinically or through laboratory tests [6567]. According to the procedure, serum samples have to be collected from symptomatic individuals with one of the following conditions: a) lives in or comes from areas in Colombia without verified transmission of the virus, b) comes from another country with or without Zika active circulation, c) belongs to an at-risk group. The samples are tested using molecular diagnostics based on RT-PCR [107, 108]. If the patient lives in or comes from areas with ongoing transmission of the virus and is exhibiting Zika-like symptoms that cannot be explained by other conditions, the cases are added to the surveillance system as clinically confirmed [107, 108]. Our model incorporates asymptomatic transmission of the ZIKV, which has proven to be significant [6] and we then estimated the proportion of symptomatic ZIKV infections reported (1/EFs) and the proportion of total ZIKV infections reported (1/EF). However, the restriction over laboratory testing may bias the results, as clinical testing relies on the symptomatology of the patient, the presence of similar viruses in the area, and the judgment of the doctor. Moreover, those who are tested must be sufficiently ill to visit the facility, but in many developing countries household economics may instead necessitate the individual to instead go to work.

We also estimated that the proportion of horizontal ZIKV infections in the municipalities studied was generally below 3%, which is inconsistent with the interval (4.44% (95% CI: 0.30%-23.02%)) presented in [59]. The sexual pathway of Zika has a small percentage contribution in the spread dynamics, however, these percentages are equivalent to a relevant number of infections that can be prevented through adequate sexual practices. It is important to note that these estimates were found considering that approximately 7% of the encounters were unprotected since the individuals involved were not incorporating sexual practices to protect themselves from sexually transmitted infections, including ZIKV. This proportion of risky interaction was calculated using the data from the Colombia Ministry of Health and Social Protection and Profamilia [9597], which is not specific for each municipality. Specific factors such as income, level of education and access to medical care might expand or reduce this figure in a particular area. Detailed information concerning contraceptive use by municipality would allow us to improve our estimates for ZIKV horizontal transmission.

In cases where ZIKV is transmitted to a pregnant woman, her child may develop a variety of neurological disorders, such as GBS. In recording and comparing these numbers it is critical to be cognizant of potential false positives. For instance [115] report very high rates of false positives when testing for microcephaly (up to 82.5%) and GBS (up to 56%). These false-positives can have highly dramatic consequences, as indicated by a >90% increase in illegal abortion requests in Latin America during the 2016 epidemic [116]. Progress in the development of ZIKV diagnostic tests is outlined in [117], while the difficulties in obtaining reliable results have been discussed in [118121]. Accurately detecting and estimating ZIKV cases is a major concern, but at present our proposed model does not consider such inconsistencies.

We also used the proposed model to provide some insight into the impact public policies could have on mitigating ZIKV spread. The experiments did not explicitly implement a policy, such as mosquito spraying, but instead simulated an estimate of what such a policy could mean with respect to changes in model parameterization. Given the relatively few cases of ZIKV due to sexual transmission, policies aimed at that particular pathway did not significantly impact overall spread. However, the associated risk of not putting resources toward mitigating sexual transmission is large given both potential immediate and long-term consequences and associated costs. In order to gain more granular insight the policies could be more concretely studied and related to specific value changes in parameterization. Moreover, the proposed model could instead form a basis for an network or agent-based simulation that would provide much more detailed feedback (e.g., [122]), but has very high computational burden and issues of calibration and relevance of output to the specifics “on the ground” is not clear. Moreover, the municipalities are considered independent entities, but in reality share common trade routes, transportation paths and may have many individuals commuting between them each day. Mitigating this level of interaction is not presently considered, but a patch model building from that proposed could provide detail on a larger scale than at a municipality level.

4.1 Conclusions

We constructed a compartmental model to represent the spread dynamics of ZIKV, including its two main transmission pathways: mosquito bites and sexual contact. The structure of our model allows for the estimation of cases by symptoms and sex. This is an important feature that can be utilized in the future to study specific populations, such as pregnant women who could be affected by the congenital diseases associated with ZIKV. We can also use it to study specific simulation scenarios, for example, the use of condoms as a health policy against the spread of Zika.

The ZIKV is a very atypical flavivirus, not only because of its causal association with severe disorders but also because of its multiple transmission pathways. The mathematical model we presented can be easily modified to add mechanisms that have not been explored, including non-sexual person-to-person transmission, which appears to be the pathway of the case reported in [14]. Nonetheless, the sexual transmission of the virus should not be neglected, as the fact that the Zika virus is transmissible from human to human implies a change in the global propagation dynamics. As humans act as vectors and reservoirs of the virus, the non-vector propagation is not affected by environmental conditions, such as seasonal change. This is a critical point that needs to be addressed in further research, in order to determine how the addition of these pathways impacts the global spread dynamics of the virus. Finally, considering that the ZIKV can be horizontal [123] and vertically [124, 125] transmitted from mosquito-to-mosquito, it would also be interesting to study the role of these interactions in the spread dynamics of the ZIKV. Certainly, the realization of these studies requires more information about the aforementioned mechanisms.

Supporting information

S1 Appendix

(PDF)

Data Availability

The used weekly incidence data was reported to the Colombian National Public Health Surveillance System (SIVIGILA) from 2015 to 2017 as General Zika Disease~(code 895), which includes neurological disorders probably associated with a ZIKV infection, and is available to the public as outlined in [65, 66, 67]. The website is: http://portalsivigila.ins.gov.co/Paginas/Vigilancia-Rutinaria.aspx.

Funding Statement

The Administrative Department of Science, Technology and Innovation of Colombia (COLCIENCIAS) sponsored this project, as a part of the Nexo Global program.

References

  • 1. Weaver SC, Costa F, Garcia-Blanco MA, Ko AI, Ribeiro GS, Saade G, et al. Zika virus: History, emergence, biology, and prospects for control. Antiviral Research. 2016;130:69–80. doi: 10.1016/j.antiviral.2016.03.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Kindhauser MK, Allen T, Frank V, Santhana RS, Dye C. Zika: the origin and spread of a mosquito-borne virus. Bulletin of the World Health Organization. 2016;94(9):675–686C. doi: 10.2471/BLT.16.171082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Wikan N, Smith DR. Zika virus: History of a newly emerging arbovirus. The Lancet Infectious Diseases. 2016;16(7):e119–e126. doi: 10.1016/S1473-3099(16)30010-X [DOI] [PubMed] [Google Scholar]
  • 4. Charrel RN, Leparc-Goffart I, Pas S, de Lamballerie X, Koopmans M, Reusken C. Background review for diagnostic test development for Zika virus infection. Bulletin of the World Health Organization. 2016;94(8):574–584D. doi: 10.2471/BLT.16.171207 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Paixão ES, Barreto F, Da Glória Teixeira M, Da Conceição N Costa M, Rodrigues LC. History, epidemiology, and clinical manifestations of Zika: A systematic review. American Journal of Public Health. 2016;106(4):606–612. doi: 10.2105/AJPH.2016.303112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Haby MM, Pinart M, Elias V, Reveiz L. Prevalence of asymptomatic Zika virus infection: a systematic review. Bulletin of the World Health Organization. 2018;96(6):402–413D. doi: 10.2471/BLT.17.201541 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Duffy MR, Chen THH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, federated states of Micronesia. New England Journal of Medicine. 2009;360(24):2536–2543. doi: 10.1056/NEJMoa0805715 [DOI] [PubMed] [Google Scholar]
  • 8. Avšic Županc T, Petrovec M. Zika: an old virus with a new face. Slovenian Journal of Public Health. 2016;55(4):228. doi: 10.1515/sjph-2016-0031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Besnard M, Lastère S, Teissier A, Cao-Lormeau VM, Musso D. Evidence of perinatal transmission of zika virus, French Polynesia, December 2013 and February 2014. Eurosurveillance. 2014;19(13):8–11. doi: 10.2807/1560-7917.ES2014.19.13.20751 [DOI] [PubMed] [Google Scholar]
  • 10. Colt S, Garcia-Casal MN, Peña-Rosas JP, Finkelstein JL, Rayco-Solon P, Weise Prinzo ZC, et al. Transmission of Zika virus through breast milk and other breastfeeding-related bodily-fluids: A systematic review. PLoS Neglected Tropical Diseases. 2017;11(4):e0005528. doi: 10.1371/journal.pntd.0005528 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Musso D, Nhan T, Robin E, Roche C. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia. Euro Surveill. 2014;19(November 2013):20761. 10.2807/1560-7917.ES2014.19.14.20761 [DOI] [PubMed] [Google Scholar]
  • 12. Nogueira ML, Estofolete CF, Terzian ACB, Mascarin do Vale EPB, da Silva RCMA, da Silva RF, et al. Zika Virus Infection and Solid Organ Transplantation: A New Challenge. American Journal of Transplantation. 2017;17(3):791–795. doi: 10.1111/ajt.14047 [DOI] [PubMed] [Google Scholar]
  • 13. Moreira J, Peixoto TM, Siqueira AM, Lamas CC. Sexually acquired Zika virus: a systematic review. Clinical Microbiology and Infection. 2017;23(5):296–305. doi: 10.1016/j.cmi.2016.12.027 [DOI] [PubMed] [Google Scholar]
  • 14. Krow-Lucal ER, Novosad SA, Dunn AC, Brent CR, Savage HM, Faraji A, et al. Zika virus infection in patient with no known risk factors, Utah, USA, 2016. Emerging Infectious Diseases. 2017;23(8):1260–1267. doi: 10.3201/eid2308.170479 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Gourinat AC, O’Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M. Detection of zika virus in urine. Emerging Infectious Diseases. 2015;21(1):84–86. doi: 10.3201/eid2101.140894 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Joguet G, Mansuy JM, Matusali G, Hamdi S, Walschaerts M, Pavili L, et al. Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study. The Lancet Infectious Diseases. 2017;17(11):1200–1208. doi: 10.1016/S1473-3099(17)30444-9 [DOI] [PubMed] [Google Scholar]
  • 17. Musso D, Roche C, Nhan TX, Robin E, Teissier A, Cao-Lormeau VM. Detection of Zika virus in saliva. Journal of Clinical Virology. 2015;68:53–55. doi: 10.1016/j.jcv.2015.04.021 [DOI] [PubMed] [Google Scholar]
  • 18. Atkinson B, Hearn P, Afrough B, Lumley S, Carter D, Aarons EJ, et al. Detection of zika virus in semen. Emerging Infectious Diseases. 2016;22(5):940. doi: 10.3201/eid2205.160107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Dupont-Rouzeyrol M, Biron A, OConnor O, Huguon E, Descloux E. Infectious Zika viral particles in breastmilk. The Lancet. 2016;387(10023):1056. doi: 10.1016/S0140-6736(16)00624-3 [DOI] [PubMed] [Google Scholar]
  • 20. Prisant N, Bujan L, Benichou H, Hayot PH, Pavili L, Lurel S, et al. Zika virus in the female genital tract. The Lancet Infectious Diseases. 2016;16(9):1000–1001. doi: 10.1016/S1473-3099(16)30193-1 [DOI] [PubMed] [Google Scholar]
  • 21. Fréour T, Mirallié S, Hubert B, Splingart C, Barrière P, Maquart M, et al. Sexual transmission of Zika virus in an entirely asymptomatic couple returning from a Zika epidemic area, France, April 2016. Eurosurveillance. 2016;21(23):8–10. 10.2807/1560-7917.ES.2016.21.23.30254 [DOI] [PubMed] [Google Scholar]
  • 22. Brooks RB, Carlos MP, Myers RA, White MG, Bobo-Lenoci T, Aplan D, et al. Likely Sexual Transmission of Zika Virus from a Man with No Symptoms of Infection—Maryland, 2016. MMWR Morbidity and Mortality Weekly Report. 2016;65(34):915–916. doi: 10.15585/mmwr.mm6534e2 [DOI] [PubMed] [Google Scholar]
  • 23. Deckard DT, Chung WM, Brooks JT, Smith JC, Woldai S, Hennessey M, et al. Male-to-Male Sexual Transmission of Zika Virus—Texas, January 2016. MMWR Morbidity and Mortality Weekly Report. 2016;65(14):372–374. doi: 10.15585/mmwr.mm6514a3 [DOI] [PubMed] [Google Scholar]
  • 24. Davidson A, Slavinski S, Komoto K, Rakeman J, Weiss D. Suspected Female-to-Male Sexual Transmission of Zika Virus—New York City, 2016. MMWR Morbidity and Mortality Weekly Report. 2016;65(28):716–717. doi: 10.15585/mmwr.mm6528e2 [DOI] [PubMed] [Google Scholar]
  • 25. Krauer F, Riesen M, Reveiz L, Oladapo OT, Martínez-Vega R, Porgo TV, et al. Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain–Barré Syndrome: Systematic Review. PLoS Medicine. 2017;14(1):1–27. doi: 10.1371/journal.pmed.1002203 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Yuki N, Hartung HP. Guillain Barré syndrome. Autoimmunity Reviews. 2017;16(1):96–101. doi: 10.1016/j.autrev.2016.09.022 [DOI] [PubMed] [Google Scholar]
  • 27. Ogden SC, Hammack C, Tang H. Zika virus and neural developmental defects: building a case for a cause. Science China Life Sciences. 2016;59(5):536–538. doi: 10.1007/s11427-016-5053-2 [DOI] [PubMed] [Google Scholar]
  • 28. Moore CA, Staples JE, Dobyns WB, Pessoa A, Ventura CV, da Fonseca EB, et al. Characterizing the Pattern of Anomalies in Congenital Zika Syndrome for Pediatric Clinicians. JAMA Pediatrics. 2017;171(3):288. doi: 10.1001/jamapediatrics.2016.3982 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.World Health Organization. Zika Virus. Research agenda (Oct. 2016); 2016. https://apps.who.int/iris/bitstream/handle/10665/250615/WHO-ZIKV-PHR-16.1-eng.pdf?sequence=1.
  • 30. Poland GA, Kennedy RB, Ovsyannikova IG, Palacios R, Ho PL, Kalil J. Development of vaccines against Zika virus. The Lancet Infectious Diseases. 2018;18(7):e211–e219. doi: 10.1016/S1473-3099(18)30063-X [DOI] [PubMed] [Google Scholar]
  • 31.World Health Organization. Prevention of sexual transmission of Zika virus. Interim guidance update; 2016. https://apps.who.int/iris/bitstream/handle/10665/204421/WHO_ZIKV_MOC_16.1_eng.pdf?sequence=1.
  • 32.Raman, Velayudhan, Yadav A, Mnzava M, Quinones, Knox. Vector control operations framework for Zika virus; 2016.
  • 33.Oladapo OT, Souza JP, De Mucio B, de León RGP, Perea W, Gülmezoglu AM. WHO interim guidance on pregnancy management in the context of Zika virus infection; 2016. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(16)30098-5/fulltext. [DOI] [PubMed]
  • 34.World Health Organization. Psychosocial support for pregnant women and for families with microcephaly and other neurological complications in the context of Zika virus—Interim guidance for health-care providers; 2016. http://apps.who.int/iris/bitstream/10665/204492/1/WHO_ZIKV_MOC_16.6_eng.pdf%0Ahttp://apps.who.int/iris/bitstream/10665/204492/1/WHO_ZIKV_MOC_16.6_eng.pdf?ua=1.
  • 35.World Health Organization. Infant feeding in areas of Zika virus transmission. Guideline; 2016. https://apps.who.int/iris/bitstream/handle/10665/208875/9789241549660_eng.pdf?sequence=1. [PubMed]
  • 36.World Health Organization. Maintaining a safe and adequate blood supply during Zika virus outbreaks. Interim guidance. February 2016.; 2016. http://apps.who.int/iris/bitstream/10665/204436/1/.
  • 37.World Health Organization. Report of the WHO Ad-hoc Advisory Group on aircraft disinsection for controlling the international spread of vector- borne diseases; 2016. https://apps.who.int/iris/bitstream/handle/10665/205795/WHO_HSE_GCR_2016.12_eng.pdf?sequence=1.
  • 38.World Health Organization. Surveillance for Zika virus infection, microcephaly and Guillain-Barré syndrome; 2016. https://apps.who.int/iris/bitstream/handle/10665/204897/WHO_ZIKV_SUR_16.2_eng.pdf?sequence=1&isAllowed=y.
  • 39.World Health Organization. Birth defects surveillance training: facilitator’s guide; 2015. https://apps.who.int/iris/bitstream/handle/10665/177871/9789241549288_eng.pdf?sequence=1.
  • 40.World Health Organization. Laboratory testing for Zika virus infection. Interim guidance; 2016. https://apps.who.int/iris/bitstream/handle/10665/204671/WHO_ZIKV_LAB_16.1_eng.pdf?sequence=1.
  • 41.World Health Organization. Zika Virus (ZIKV) Classification Table—Data as of 15 Frebruary 2018; 2018. http://apps.who.int/iris/bitstream/handle/10665/260419/zika-classification-15Feb18-eng.pdf?sequence=1.
  • 42.National Ministry of Health and Social Protection (Colombia). Press relase No 274, 2015. Ministry of Health and Social Protection confirms the first nine Zika cases in Colombia.; 2015. https://www.minsalud.gov.co/Paginas/Confirmados-primeros-casos-de-virus-del-zika-en-Colombia.aspx.
  • 43.National Ministry of Health and Social Protection (Colombia). Press release No 155, 2016. Colombia, the first country on the continent to declare a close to the Zika epidemic; 2016. https://www.minsalud.gov.co/Paginas/Colombia-primer-pais-del-continente-que-cierra-epidemia-de-zika.aspx.
  • 44.World Health Organization, Pan American Health Organization. Alerta Epidemiológica—Síndrome neurológico, anomalías congénitas e infección por virus Zika. Implicaciones para la salud pública en las Américas.; 2015. https://www.paho.org/hq/dmdocuments/2015/2015-dic-1-cha-alerta-epi-zika-sindrome-neuro.pdf.
  • 45.National Institute of Health (Colombia). Circular Externa 063 de 2016; 2016. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/IA/INS/Circular-externa-063-de-2015-ins.pdf.
  • 46.National Institute of Health (Colombia). Colombia Weekly Epidemiological Bulletin, Week 52, 2016.; 2016. http://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2016%20Bolet%C3%ADn%20epidemiol%C3%B3gico%20semana%2052%20-.pdf.
  • 47.National Institute of Health (Colombia). Colombia Weekly Epidemiological Bulletin, Week 52, 2017.; 2017. http://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2017%20Bolet%C3%ADn%20epidemiol%C3%B3gico%20semana%2052.pdf.
  • 48.National Institute of Health (Colombia). Colombia Weekly Epidemiological Bulletin, Week 24, 2018.; 2018. http://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2018%20Bolet%C3%ADn%20epidemiol%C3%B3gico%20semana%2024.pdf.
  • 49. Sarmiento-Ospina A, Vásquez-Serna H, Jimenez-Canizales CE, Villamil-Gómez WE, Rodriguez-Morales AJ. Zika virus associated deaths in Colombia. The Lancet Infectious Diseases. 2016;16(5):523–524. doi: 10.1016/S1473-3099(16)30006-8 [DOI] [PubMed] [Google Scholar]
  • 50. Arzuza-Ortega L, Polo A, Pérez-Tatis G, López-García H, Parra E, Pardo-Herrera LC, et al. Fatal sickle cell disease and zika virus infection in girl from Colombia. Emerging Infectious Diseases. 2016;22(5):925–927. doi: 10.3201/eid2205.151934 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Wilson J, Malone R, Gagen JS, Pabayo R. Zika Virus Disease: A Simple Model Approach to Rapid Impact Assessment. bioRxiv. 2016; p. 044248. [Google Scholar]
  • 52. Ding C, Tao N, Zhu Y. A mathematical model of Zika virus and its optimal control. Chinese Control Conference, CCC. 2016;2016-Augus(1):2642–2645. 10.1101/044248 [DOI] [Google Scholar]
  • 53. Perkins TA, Siraj AS, Ruktanonchai CW, Kraemer MUG, Tatem AJ. Model-based projections of Zika virus infections in childbearing women in the Americas. Nature Microbiology. 2016;2(12):16126. doi: 10.1038/nmicrobiol.2016.126 [DOI] [PubMed] [Google Scholar]
  • 54. Nishiura H, Mizumoto K, Villamil-Gómez WE, Rodríguez-Morales AJ. Preliminary estimation of the basic reproduction number of Zika virus infection during Colombia epidemic, 2015-2016. Travel Medicine and Infectious Disease. 2016;14(3):274–276. doi: 10.1016/j.tmaid.2016.03.016 [DOI] [PubMed] [Google Scholar]
  • 55. Kucharski AJ, Funk S, Eggo RM, Mallet HP, Edmunds WJ, Nilles EJ. Transmission Dynamics of Zika Virus in Island Populations: A Modelling Analysis of the 2013-14 French Polynesia Outbreak. PLoS Neglected Tropical Diseases. 2016;10(5):1–15. doi: 10.1371/journal.pntd.0004726 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Moreno VM, Espinoza B, Bichara D, Holechek SA, Castillo-Chavez C. Role of short-term dispersal on the dynamics of Zika virus in an extreme idealized environment. Infectious Disease Modelling. 2017;2(1):21–34. doi: 10.1016/j.idm.2016.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Zhang Q, Sun K, Chinazzi M, Pastore y Piontti A, Dean NE, Rojas DP, et al. Spread of Zika virus in the Americas. Proceedings of the National Academy of Sciences. 2017;114(22):E4334–E4343. doi: 10.1073/pnas.1620161114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Reilly KMO, Lowe R, Edmunds WJ, Mayaud P, Eggo RM, Funk S, et al. Projecting the end of the Zika virus epidemic in Latin America: a modelling analysis. bioRxiv. 2018; p. 1–25. 10.1101/323915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Gao D, Lou Y, He D, Porco TC, Kuang Y, Chowell G, et al. Prevention and Control of Zika as a Mosquito-Borne and Sexually Transmitted Disease: A Mathematical Modeling Analysis. Scientific Reports. 2016;6(1):28070. doi: 10.1038/srep28070 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Towers S, Brauer F, Castillo-Chavez C, Falconar AKI, Mubayi A, Romero-Vivas CME. Estimate of the reproduction number of the 2015 Zika virus outbreak in Barranquilla, Colombia, and estimation of the relative role of sexual transmission. Epidemics. 2016;17:50–55. doi: 10.1016/j.epidem.2016.10.003 [DOI] [PubMed] [Google Scholar]
  • 61. Sánchez-Montalvá A, Pou D, Sulleiro E, Salvador F, Bocanegra C, Treviño B, et al. Zika virus dynamics in body fluids and risk of sexual transmission in a non-endemic area. Tropical Medicine and International Health. 2018;23(1):92–100. doi: 10.1111/tmi.13019 [DOI] [PubMed] [Google Scholar]
  • 62. Nicastri E, Castilletti C, Liuzzi G, Iannetta M, Capobianchi MR, Ippolito G. Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016. Eurosurveillance. 2016;21(32):1–4. doi: 10.2807/1560-7917.ES.2016.21.32.30314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Agusto FB, Bewick S, Fagan WF. Mathematical model for Zika virus dynamics with sexual transmission route. Ecological Complexity. 2017;29:61–81. doi: 10.1016/j.ecocom.2016.12.007 [DOI] [Google Scholar]
  • 64. Maxian O, Neufeld A, Talis EJ, Childs LM, Blackwood JC. Zika virus dynamics: When does sexual transmission matter? Epidemics. 2017;21:48–55. https://doi.org/0.1016/j.epidem.2017.06.003 [DOI] [PubMed] [Google Scholar]
  • 65.National System of Public Health Surveillance (Colombia). Routine Surveillance by Event Minicipality 2015; 2015. http://portalsivigila.ins.gov.co/rutinaria/historica/rutinaria_2015.xlsx.
  • 66.National System of Public Health Surveillance (Colombia). Routine Surveillance by Event Minicipality 2016; 2016. http://portalsivigila.ins.gov.co/rutinaria/historica/rutinaria_2016.xlsx.
  • 67.National System of Public Health Surveillance (Colombia). Routine Surveillance by Event Minicipality 2017; 2017. http://portalsivigila.ins.gov.co/rutinaria/historica/rutinaria_2017.xlsx.
  • 68. Yakob L, Clements ACA. A Mathematical Model of Chikungunya Dynamics and Control: The Major Epidemic on Réunion Island. PLoS ONE. 2013;8(3):1–6. doi: 10.1371/journal.pone.0057448 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Sim S, Jupatanakul N, Dimopoulos G. Mosquito immunity against arboviruses. Viruses. 2014;6(11):4479–4504. doi: 10.3390/v6114479 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Smith DL, Battle KE, Hay SI, Barker CM, Scott TW, McKenzie FE. Ross, Macdonald, and a theory for the dynamics and control of mosquito-transmitted pathogens. PLoS Pathogens. 2012;8(4). doi: 10.1371/journal.ppat.1002588 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Reiner RC Jr, Perkins TA, Barker CM, Niu T, Chaves LF, Ellis AM, et al. A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970–2010. Journal of The Royal Society Interface. 2013;10(81):20120921. doi: 10.1098/rsif.2012.0921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Focks DA, Brenner RJ, Hayes J, Daniels E. Transmission thresholds for dengue in terms of Aedes aegypti pupae per person with discussion of their utility in source reduction efforts. American Journal of Tropical Medicine and Hygiene. 2000;62(1):11–18. doi: 10.4269/ajtmh.2000.62.11 [DOI] [PubMed] [Google Scholar]
  • 73. Focks DA, Alexander N. Multicountry study of Aedes aegypti pupal productivity survey methodology. Tropical Medicine. 2006;31:56. [Google Scholar]
  • 74. Romero-Vivas CME, Arango-Padilla P, Falconar aKI. Pupal-productivity surveys to identify the key container habitats of Aedes aegypti (L.) in Barranquilla, the principal seaport of Colombia. Annals of tropical medicine and parasitology. 2006;100 Suppl(1):S87–S95. doi: 10.1179/136485906X105543 [DOI] [PubMed] [Google Scholar]
  • 75. Alcalá L, Quintero J, González-Uribe C, Brochero H. Productividad de Aedes aegypti (L.) (Diptera: Culicidae) en viviendas y espacios públicos en una ciudad endémica para dengue en Colombia. Biomédica. 2015;35(2):258–268. 10.7705/biomedica.v35i2.2567 [DOI] [PubMed] [Google Scholar]
  • 76. Fuentes-Vallejo M, Higuera-Mendieta DR, García-Betancourt T, Alcalá-Espinosa LA, García-Sánchez D, Munévar-Cagigas DA, et al. Territorial analysis of Aedes aegypti distribution in two Colombian cities: a chorematic and ecosystem approach. Cadernos de Saúde Pública. 2015;31(3):517–530. doi: 10.1590/0102-311x00057214 [DOI] [PubMed] [Google Scholar]
  • 77. Padmanabha H, Durham D, Correa F, Diuk-Wasser M, Galvani A. The Interactive Roles of Aedes aegypti Super-Production and Human Density in Dengue Transmission. PLoS Neglected Tropical Diseases. 2012;6(8). doi: 10.1371/journal.pntd.0001799 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357(9263):1149–1153. doi: 10.1016/S0140-6736(00)04331-2 [DOI] [PubMed] [Google Scholar]
  • 79. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. The New England Journal of Medicine. 1994;331(6):341–346. doi: 10.1056/NEJM199408113310601 [DOI] [PubMed] [Google Scholar]
  • 80. Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: A systematic review. Aids. 2014;28(10):1509–1519. doi: 10.1097/QAD.0000000000000298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Krow-Lucal ER, Biggerstaff BJ, Staples JE. Estimated incubation period for zika virus disease. Emerging Infectious Diseases. 2017;23(5):841–844. doi: 10.3201/eid2305.161715 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Fourié T, Grard G, Leparc-Goffart I, Briolant S, Fontaine A. Variability of Zika Virus Incubation Period in Humans. Open forum infectious diseases. 2018;5(11):ofy261–ofy261. doi: 10.1093/ofid/ofy261 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Andraud M, Hens N, Marais C, Beutels P. Dynamic epidemiological models for dengue transmission: a systematic review of structural approaches. PloS one. 2012;7(11):e49085. doi: 10.1371/journal.pone.0049085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Padmanabhan P, Seshaiyer P, Castillo-Chavez C. Mathematical modeling, analysis and simulation of the spread of Zika with influence of sexual transmission and preventive measures. Letters in Biomathematics. 2017;4(1):148–166. doi: 10.30707/LiB4.1Padmanabhan [DOI] [Google Scholar]
  • 85. Russell K, Hills SL, Oster AM, Porse CC, Danyluk G, Cone M, et al. Male-to-female sexual transmission of zika virus-United States, January-April 2016. Clinical Infectious Diseases. 2017;64(2):211–213. doi: 10.1093/cid/ciw692 [DOI] [PubMed] [Google Scholar]
  • 86. Foy BD, Kobylinski KC, Foy JLC, Blitvich BJ, da Rosa AT, Haddow AD, et al. Probable Non-Vector-borne Transmission of Zika Virus, Colorado, USA. Emerging Infectious Diseases. 2011;17(5):880–882. doi: 10.3201/eid1705.101939 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Arsuaga M, Bujalance SG, Díaz-Menéndez M, Vázquez A, Arribas JR. Probable sexual transmission of Zika virus from a vasectomised man. The Lancet Infectious diseases. 2016;16(10):1107. doi: 10.1016/S1473-3099(16)30320-6 [DOI] [PubMed] [Google Scholar]
  • 88. Lessler J, Ott CT, Carcelen AC, Konikoff JM, Williamson J, Bi Q, et al. Times to key events in Zika virus infection and implications for blood donation: A systematic review. Bulletin of the World Health Organization. 2016;94(11):841–849. doi: 10.2471/BLT.16.174540 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Paz-Bailey G, Rosenberg ES, Doyle K, Munoz-Jordan J, Santiago GA, Klein L, et al. Persistence of Zika Virus in Body Fluids—Preliminary Report. New England Journal of Medicine. 2017; p. NEJMoa1613108. 10.1056/NEJMoa1613108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Reusken C, Pas S, Geurtsvankessel C, Mögling R, van Kampen J, Langerak T, et al. Longitudinal follow-up of Zika virus RNA in semen of a traveller returning from Barbados to the Netherlands with Zika virus disease, march 2016. Eurosurveillance. 2016;21(23):2–5. doi: 10.2807/1560-7917.ES.2016.21.23.30251 [DOI] [PubMed] [Google Scholar]
  • 91. García-Bujalance S, Gutiérrez-Arroyo A, De la Calle F, Díaz-Menéndez M, Arribas JR, García-Rodríguez J, et al. Persistence and infectivity of Zika virus in semen after returning from endemic areas: Report of 5 cases. Journal of Clinical Virology. 2017;96:110–115. doi: 10.1016/j.jcv.2017.10.006 [DOI] [PubMed] [Google Scholar]
  • 92. Gaskell KM, Houlihan C, Nastouli E, Checkley AM. Persistent zika virus detection in semen in a traveler returning to the United Kingdom from Brazil, 2016. Emerging Infectious Diseases. 2017;23(1):137–139. doi: 10.3201/eid2301.161300 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93. Huits R, De Smet B, Ariën KK, Van Esbroeck M, Bottieau E, Cnops L. Zika virus in semen: a prospective cohort study of symptomatic travellers returning to Belgium. Bulletin of the World Health Organization. 2017;95(12):802–809. doi: 10.2471/BLT.17.181370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Mead PS, Duggal NK, Hook SA, Delorey M, Fischer M, Olzenak McGuire D, et al. Zika Virus Shedding in Semen of Symptomatic Infected Men. New England Journal of Medicine. 2018;378(15):1377–1385. doi: 10.1056/NEJMoa1711038 [DOI] [PubMed] [Google Scholar]
  • 95.Profamilia, National Ministry of Health and Social Protection (Colombia). Colombia Demographic and Health Survey 2015—Key Findings; 2015. https://www.dhsprogram.com/pubs/pdf/SR239/SR239.pdf.
  • 96.Profamilia, National Ministry of Health and Social Protection (Colombia). Colombia Demographic and Health Survey 2015—Final Report, part I.; 2015. https://www.dhsprogram.com/pubs/pdf/SR239/SR239.pdf.
  • 97.Profamilia, National Ministry of Health and Social Protection (Colombia). Colombia Demographic and Health Survey 2015—Final Report, part II; 2015. https://www.dhsprogram.com/pubs/pdf/SR239/SR239.pdf.
  • 98.EL TIEMPO Casa Editorial. Los colombianos en la cama; 2001. http://www.eltiempo.com/archivo/documento/MAM-709556.
  • 99.National Administrative Department of Statistics (Colombia). Population series 1985-2020; 2005. http://www.dane.gov.co/files/investigaciones/poblacion/seriesp85_20/EstimacionesProyecciones1985__020.xls.
  • 100. Da Cruz Ferreira DA, Degener CM, De Almeida Marques-Toledo C, Bendati MM, Fetzer LO, Teixeira CP, et al. Meteorological variables and mosquito monitoring are good predictors for infestation trends of Aedes aegypti, the vector of dengue, chikungunya and Zika. Parasites and Vectors. 2017;10(1):1–11. doi: 10.1186/s13071-017-2025-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Sutherst RW. Global change and human vulnerability to vector-borne diseases. Clinical microbiology reviews. 2004;17(1):136–73. doi: 10.1128/CMR.17.1.136-173.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.España G. Large-scale vector-borne disease agent-based model, with application to Chikungunya in Colombia [phdthesis]. Universidad Nacional de Colombia; 2015.
  • 103.National Administrative Department of Statistics (Colombia). COLOMBIA. Necesidades Básicas Insatisfechas—NBI, por total, cabecera y resto, según municipio y nacional; 2012. https://www.dane.gov.co/censo/files/resultados/NBI_total_dpto_30_Jun_2012.xls.
  • 104.Tolosa N. Protocolo de Vigilancia en Salud Pública Enfermedad por Virus Zika; 2016. http://bvs.minsa.gob.pe/local/MINSA/3449.pdf.
  • 105.Bates D, Sarkar D. R: Optimization using PORT routines;. https://www.rdocumentation.org/packages/stats/versions/3.6.0/topics/nlminb.
  • 106.Gay DM. Usage summary for selected optimization routines; 1990. https://ms.mcmaster.ca/bolker/misc/port.pdf.
  • 107.National Institute of Health (Colombia). Circular Conjunta Externa 043 de 2015; 2015. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/circular-conjunta-externa-0043.pdf.
  • 108.National Institute of Health (Colombia). Circular Conjunta Externa 061 de 2015; 2015. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/circular-conjunta-061-de-2015-ins.pdf.
  • 109. Plourde AR, Bloch EM. A literature review of zika virus. Emerging Infectious Diseases. 2016;22(7):1185–1192. doi: 10.3201/eid2207.151990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110. Undurraga EA, Halasa YA, Shepard DS. Use of expansion factors to estimate the burden of dengue in Southeast Asia: a systematic analysis. PLoS neglected tropical diseases. 2013;7(2):e2056–e2056. doi: 10.1371/journal.pntd.0002056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111. Pacheco O, Beltrán M, Nelson CA, Valencia D, Tolosa N, Farr SL, et al. Zika Virus Disease in Colombia—Preliminary Report. New England Journal of Medicine. 2016; p. NEJMoa1604037. 10.1056/NEJMoa1604037 [DOI] [PubMed] [Google Scholar]
  • 112. Gardner LM, Bóta A, Gangavarapu K, Kraemer MUG, Grubaugh ND. Inferring the risk factors behind the geographical spread and transmission of Zika in the Americas. PLoS neglected tropical diseases. 2018;12(1):e0006194–e0006194. doi: 10.1371/journal.pntd.0006194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113. Tesla B, Demakovsky LR, Mordecai EA, Ryan SJ, Bonds MH, Ngonghala CN, et al. Temperature drives Zika virus transmission: evidence from empirical and mathematical models. Proceedings of the Royal Society B: Biological Sciences. 2018;285(1884):20180795. doi: 10.1098/rspb.2018.0795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114. Huber JH, Childs ML, Caldwell JM, Mordecai EA. Seasonal temperature variation influences climate suitability for dengue, chikungunya, and Zika transmission. PLOS Neglected Tropical Diseases. 2018;12(5):1–20. doi: 10.1371/journal.pntd.0006451 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115. Bautista LE, Herrera VM. An assessment of public health surveillance of Zika virus infection and potentially associated outcomes in Latin America. BMC public health. 2018;18(1):656–656. doi: 10.1186/s12889-018-5566-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116. Fischer C, Pedroso C, Mendrone A, Filippis AMBd, Vallinoto ACR, Ribeiro BM, et al. External Quality Assessment for Zika Virus Molecular Diagnostic Testing, Brazil. 2018;24(5):888. 10.3201/eid2405.171747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117. Chua A, Prat I, Nuebling CM, Wood D, Moussy F. Update on Zika Diagnostic Tests and WHO’s Related Activities. PLoS neglected tropical diseases. 2017;11(2):e0005269–e0005269. doi: 10.1371/journal.pntd.0005269 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118. Fischer C, Drosten C, Drexler JF. The difficulties in obtaining reliable Zika virus diagnostics. The Lancet Infectious Diseases. 2019;19(3):240–241. doi: 10.1016/S1473-3099(19)30049-0 [DOI] [PubMed] [Google Scholar]
  • 119. Musso D, Gubler DJ. Zika Virus. Clinical Microbiology Reviews. 2016;29(3):487–524. doi: 10.1128/CMR.00072-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120. Munoz-Jordan JL. Diagnosis of Zika Virus Infections: Challenges and Opportunities. The Journal of Infectious Diseases. 2017;216(10):S951–S956. doi: 10.1093/infdis/jix502 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121. Hay JA, Nouvellet P, Donnelly CA, Riley S. Potential inconsistencies in Zika surveillance data and our understanding of risk during pregnancy. PLOS Neglected Tropical Diseases. 2018;12(12):1–20. doi: 10.1371/journal.pntd.0006991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122. Ventresca M, Aleman D. Evaluation of strategies to mitigate contagion spread using social network characteristics. Social Networks. 2013;35(1):75–88. doi: 10.1016/j.socnet.2013.01.002 [DOI] [Google Scholar]
  • 123. Campos SS, Fernandes RS, Dos Santos AAC, De Miranda RM, Telleria EL, Ferreira-De-Brito A, et al. Zika virus can be venereally transmitted between Aedes aegypti mosquitoes. Parasites and Vectors. 2017;10(1):605. doi: 10.1186/s13071-017-2543-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124. Ciota AT, Bialosuknia SM, Ehrbar DJ, Kramer LD. Vertical transmission of zika virus by Aedes aegypti and Ae. Albopictus mosquitoes. Emerging Infectious Diseases. 2017;23(5):880–882. doi: 10.3201/eid2305.162041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125. Thangamani S, Huang J, Hart CE, Guzman H, Tesh RB. Vertical transmission of zika virus in aedes aegypti mosquitoes. American Journal of Tropical Medicine and Hygiene. 2016;95(5):1169–1173. doi: 10.4269/ajtmh.16-0448 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Appendix

(PDF)

Data Availability Statement

The used weekly incidence data was reported to the Colombian National Public Health Surveillance System (SIVIGILA) from 2015 to 2017 as General Zika Disease~(code 895), which includes neurological disorders probably associated with a ZIKV infection, and is available to the public as outlined in [65, 66, 67]. The website is: http://portalsivigila.ins.gov.co/Paginas/Vigilancia-Rutinaria.aspx.


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES